Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain

Blood

Volumn 87, Issue 1, 1996, Pages 273-283

  Tsujimura, Tohru ^a   Morimoto, Masahiro ^a   Hashimoto, Koji ^a   Moriyama, Yasuhiro ^a   Kitayama, Hitoshi ^a   Matsuzawa, Yuji ^a   Kitamura, Yukihiko ^a   Kanakura, Yuzuru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; MASTOCYTOMA; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

EID: 0030032943     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.273.bloodjournal871273     Document Type: Article

References (68)

1. Qiu F, Ray P, Brown K, Barker PE, Jhanwar S, Ruddle FH, Besmer P: Primary structure of c-kit: Relationship with the CSF-1/ PDGF receptor kinase family - oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 7:1003, 1988
2. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341, 1987
3. Yarden Y, Ullrich A: Growth factor receptor tyrosine kinase. Annu Rev Biochem 57:443, 1988
4. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61:203, 1990
5. Fantl WJ, Johnson DE, Williams LT: Signalling by receptor tyrosine kinases. Annu Rev Biochem 62:453, 1993
6. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A: The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88, 1988
7. Geissler EN, Ryan MA, Housman DE: The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55:185, 1988
8. Russell ES: Hereditary anemias of the mouse: A review of geneticists. Adv Genet 20:357, 1979
9. Silvers WK: The Coat Colors of Mice: A model for mammalian gene action and interaction. New York, NY, Springer-Verlag, 1979
10. Reith AD, Bernstein A: Molecular biology of the W and Steel Loci, in Davis KE, Tilghman S (eds). Genes and Phenotypes, vol 3. New York, NY, Cold Spring Harbor Laboratory, 1991, p 105
11. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, Jacobson FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV: Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213, 1990
12. Williams DE, Eisenman J, Baird A, Rauch C, Ness KV, March CJ, Park LS, Martin U, Mochizuki DY, Boswell HS, Burgess GS, Cosman D, Lyman SD: Identification of ligand for the c-kit proto-oncogene. Cell 63:167, 1990
13. Huang E, Nocka K, Beier DR, Chu TY, Buck J, Lahm HW, Wellner D, Leder P, Besmer P: The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225, 1990
14. Flanagan JG, Leder P: The kit ligand: A cell surface molecule altered in steel mutant fibroblasts. Cell 63:185, 1990
15. Copeland NG, Gilbert DJ, Cho BC, Donovan PJ, Jenkins NA, Cosman D, Anderson D, Lyman SD, Williams DF: Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 63.175, 1990
16. Rottapel R, Reedijk M, Williams DE, Lyman SD, Anderson DM, Pawson T, Bernstein A: The steel/W transduction pathway: Kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the steel factor. Mol Cell Biol 11:3043, 1991
17. Reith AD, Ellis C, Lyman SD, Anderson DM, Williams DE, Bernstein A, Pawson T: Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. EMBO J 10:2451, 1991
18. Lev S, Givol D, Yarden Y: Interkinase domain of kit contains the binding site for phosphatidylinositol 3′ kinase. Proc Natl Acad Sci USA 89:678, 1992
19. Yi T, Ihle JN: Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand. Mol Cell Biol 13:3350, 1993
20. Serve H, Hsu Y-C, Besmer P: Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells. J Biol Chem 269:6026, 1994
21. Besmer P, Murphy JE, George PC, Qiu F, Bergold PJ, Lederman L, Snyder HW, Brodeur D, Zuckerman EE, Hardy WD: A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415, 1986
22. Kuriu A, Ikeda H, Kanakura Y, Griffin JD, Druker B, Yagura H, Kitayama H, Ishikawa J, Nishiura T, Kanayama Y, Yonezawa T, Tarui S: Proliferation of human myeloid leukemia cell line associated with the tyrosine-phosphorylation and activation of the proto-oncogene c-kit product. Blood 78:2834, 1991
23. Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J, Kanayama Y, Yonezawa T, Tarui S, Griffin JD: Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 78:2962, 1991
24. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y, Kanakura Y: Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92.1736, 1993
25. Tsujimura T, Furitsu T, Morimoto M, Isozaki K, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y: Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83:2619, 1994
26. Tsujimura T, Furitsu T, Morimoto M, Kanayama Y, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y: Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol 106:377, 1995
27. Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, Sugahara H, Mitsui H, Kanayama Y, Kitamura Y, Matsuzawa Y: Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790, 1995
28. Furth I, Hagen P, Hirsch EI: Transplantable mastocytoma in the mouse containing histamine, heparin, 5-hydroxytryptamine. Proc Soc Exp Biol Med 95:824, 1957
29. Yanagisawa M, Hasegawa H, Ichiyama A, Hosoda S, Nakamura W: Comparison of serotonin-producing murine mastocytomas, P-815 and FMA3: Determination of tryptophan hydroxylase, aromatic L-amino acid decarboxylase, and cellular concentration of tryptophan, 5-hydroxytryptophan, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Biomed Res 5:19, 1984
30. Kanakura Y, Druker B, Cannistra SA, Furukawa Y, Torimoto Y, Griffin JD: Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins. Blood 76:706, 1990
31. Kanakura Y, Drucker B, Decarlo J, Cannistra SA, Griffin JD: Pholbor 12-myristate acetate 13-acetate inhibits granulocyte-macrophage colony-stimulating factor induced tyrosine phosphorylation in a human factor-dependent cell line. J Biol Chem 266:490, 1991
32. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S-I, Kunisada T, Nakauchi H, Nishikawa S-I: Expression and function of c-kit in hematopoietic progenitor cells. J Exp Med 174:63, 1991
33. Nakahata T, Spicer SS, Cantey JR, Ogawa M: Clonal assay of mouse mast cell colonies in methyl-cellulose culture. Blood 60:352, 1982
34. Nakano T, Sonoda T, Hayashi C, Yamatodani A, Kanayama Y, Yamamura T, Asai H, Yonezawa T, Kitamura Y, Galli SJ: Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal and intravenous transfer into genetically mast cell-deficient W/W mice: Evidence that cultured mast cells can give rise to both connective tissue-type and mucosal mast cells. J Exp Med 162:1025, 1985
35. Graham FL, Smith J, Russell WC, Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59, 1977
36. Koyasu S, Nakauchi H, Kitamura K, Yonehara S, Okumura K, Tada T, Yahara I: Production of interleukin 3 and γ-interferon by an antigen-specific mouse suppressor T cell clone. J Immunol 134:3130, 1985
37. Mann R, Mulligan RC, Baltimore D: Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153, 1983
38. Majumder S, Brown K, Qiu FH, Besmer P: c-kit protein, a transmembrane kinase: Identification in tissues and characterization. Mol Cell Biol 8:4896, 1988
39. Auffray C, Rougenon F: Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 107:303, 1980
40. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
41. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463, 1977
42. Larue L, Dougherty N, Porter S, Mintz B: Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a Kit kinase-domain mutation. Proc Natl Acad Sci USA 89:7816, 1992
43. Tsujimura T, Koshimizu U, Katoh H, Isozaki K, Kanakura Y, Tono T, Adachi S, Kasugai T, Tei H, Nishimune Y, Nomura S, Kitamura Y: Mast cell number in the skin of heterozygotes reflects the molecular nature of c-kit mutation. Blood 81:2530, 1993
44. Southern PJ, Berg P: Transformation of mammalian cell to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1:327, 1982
45. Wigler M, Pellicer A, Silverstein S, Axel R, Urlaub G, Chasin L: DNA-mediated transfer of the adenine phosphoribosyltransterase locus into mammalian cells. Proc Natl Acad Sci USA 76:1373, 1979
46. Laker C, Stocking C, Bergholz U, Hess N, DeLamarter JF, Ostertag W: Autocrine stimulation after transfer of the granulocyte/ macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway. Proc Natl Acad Sci USA 84:8458, 1987
47. Blume-Jensen P, Claesson-Welsh L, Siegbahn A, Zsebo KM, Westermark B, Heldin CH: Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J 10:4121, 1991
48. Ishihara K, Wood WJ, Wall R, Sakaguchi N, Michnoff C, Tucker PW, Kincade PW: Multiple B29 containing complexes on murine B lymphocytes. J Immunol 150:2253, 1993
49. Houchens DP, Ovejera AA, Barker AD: The therapy of human tumors in athymic (nude) mice, in Houchens DP, Ovejera AA (eds): Proceedings of the Symposium on the Use of Athymic (nude) Mice in Cancer Research. Gustav Fischer, New York, Stuttgart, 1978, p 267
50. Gokkel E, Grossman Z, Ramot B, Yarden Y, Rechavi G, Givol D: Structural organization of the murine c-kit proto-oncogene. Oncogene 7:1423, 1992
51. Bargmann CI, Hung M-C, Weinberg RA: Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649, 1986
52. Bargmann CI, Weinberg RA: Oncogene activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J 7:2043, 1988
53. Siegel PM, Dankort DL, Hardy WR, Muller WJ: Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol 14:7068, 1994
54. Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ: Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature 325:549, 1987
55. Woolford J, McAuliffe A, Rohrschneider LR: Activation of the feline c-fms proto-oncogene: Multiple alterations are required to generate a fully transformed phenotype. Cell 55:965, 1988
56. Roussel MF, Downing JR, Rettenmier CW, Sherr CJ: A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell 55:979, 1988
57. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458, 1993
58. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JWM, van Amstel HKP, Romeo G, Lips CJM, Buys CHCM: A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375, 1994
59. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, Fiore PPD: Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267:381, 1995
60. Herbst R, Munemitsu S, Ullrich A: Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site. Oncogene 10:369, 1995
61. 41 and W. EMBO J 9:1805, 1990
62. Reith AD, Rottapel R, Giddens E, Brady C, Forrester L, Bernstein A: W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. Genes Dev 4:390, 1990
63. Tsujimura T, Hirota S, Nomura S, Niwa Y, Yamazaki M, Tono T, Morii E, Kim HM, Kondo K, Nishimune Y, Kitamura Y: Characterization of Ws mutant allele of rats: A 12 base deletion in tyrosine kinase domain of c-kit gene. Blood 78:1942, 1991
64. Kubota T, Hikono H, Sasaki E, Sakurai M: Sequence of a bovine c-kit proto-oncogene cDNA. Gene 141:305, 1994
65. Sasaki E, Okamura H, Chikamune T, Kanai Y, Watanabe M, Naito M, Sakurai M: Cloning and expression of the chicken c-kit proto-oncogene. Gene 128:257, 1993
66. Do MS, Fitzer-Attas C, Gubbay J, Greenfeld L, Feldman M, Eisenbach L: Mouse platelet-derived growth factor α receptor: Sequence, tissue-specific expression and correlation with metastatic phenotype. Oncogene 7:1567, 1992
67. Rothwell VM, Rohrschneider LR: Murine c-fms cDNA: Cloning, sequence analysis and retroviral expression. Oncogene Res 1:311, 1987
68. Myles GM, Brandt CS, Carlberg K, Rohrschneider LR: Tyrosine 569 in the c-Fms juxtamembrane domain is essential for kinase activity and macrophage colony-stimulating factor-dependent internalization. Mol Cell Biol 14:4843, 1994